BizPac Review

CDC boss douses media’s hopes for COVID sequel

With the media sting fears over a potential sequel to the COVID-19 pandemic, the CDC’s acting director dropped a reality check on the hantavirus outbreak. Passengers aboard […]
New York Post

CDC head assures Americans hantavirus outbreak isn’t the new COVID: ‘Shouldn’t be panicking’

Acting Centers for Disease Control and Prevention Director Dr. Jay Bhattacharya urged the public not to panic over the hantavirus outbreak on a cruise ship, underscoring that it’s not like COVID-19. Bhattacharya, who also helms the National Institutes of ...
ABC7 New York

FDA blocked publication of COVID, shingles vaccine research findings

The Food and Drug Administration blocked the publication of studies that tracked the safety of the COVID-19 and shingles vaccines, an official told ABC News.

'The CDC is not even a player.' As hantavirus outbreak unfolds on ship, agency is MIA, experts say

Public health experts are questioning the U.S. government's response to the hantavirus outbreak aboard a cruise ship that involves Americans.
New York Post

CDC downplayed COVID vaccine efficacy concerns, newly released emails show

WASHINGTON — Officials at the Centers for Disease Control and Prevention (CDC) discussed how to downplay concerns about COVID-19 vaccine efficacy and avoid “too precise” comparisons between the benefits of the jab and natural immunity, according to ...

Acting CDC Director Jay Bhattacharya Called A Vaccine Study Design 'Crap.' What The Test-Negative Design Is And How We Know Whether Vaccines Measured With It Are Effective

Jay Bhattacharya dismissed the test-negative design as 'crap.' The biostatistics literature tells a different story.

CDC director overrules advisory panel, paving way for wider use of COVID-19 vaccine boosters

Caption: Dr. Rochelle Walensky, director of the Centers for Disease Control and Prevention, said she believed the 'greatest good' right now can be achieved by allowing some Americans who are front-line workers to be eligible for another Pfizer-BioNTech vaccine dose. (Susan Walsh/Reuters)